SuperworthCeribell EPS CBLL
Diluted earnings per share by quarter and over the last twelve months, from 2023.
- Last 12 months, to Jun 30, 2026
- −$1.76
- Latest quarter, Q2 FY26
- −$0.51
- Fiscal year 2025
- −$1.47
Ceribell's earnings per share was −$1.76 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.51.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.47 | n/a |
| FY2024 | −$5.43 | n/a |
| FY2023 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.51 | n/a | −$1.76 | |
| Q1 FY26 | −$0.52 | n/a | −$1.63 | |
| Q4 FY25 | −$0.36 | n/a | −$1.47 | |
| Q3 FY25 | −$0.37 | n/a | −$1.52 | |
| Q2 FY25 | −$0.38 | n/a | −$3.00 | |
| Q1 FY25 | −$0.36 | n/a | −$4.23 | |
| Q4 FY24 | −$0.41 | n/a | −$5.43 | |
| Q3 FY24 | −$1.85 | n/a | −$6.55 | |
| Q2 FY24 | −$1.61 | n/a | −$6.02 | |
| Q1 FY24 | −$1.56 | n/a | n/a | |
| Q4 FY23 | −$1.53 | n/a | n/a | |
| Q3 FY23 | −$1.32 | n/a | n/a |
Against its peers
Companies in Medical - Devices nearest Ceribell's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| CBLLCeribell | −$1.76 | |
| CNMDCONMED | $1.85 | −48% a year |
| TMDXTransMedics | $3.84 | +99% a year |
| ITGRInteger | $3.66 | +61% a year |
| LIVNLivaNova | $3.39 | |
| ELMDElectromed | $1.31 | +56% a year |
| Peer median | $3.39 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Ceribell
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.